Haridra: Difference between revisions
YogeshDeole (talk | contribs) No edit summary |
YogeshDeole (talk | contribs) No edit summary |
||
| Line 31: | Line 31: | ||
}} | }} | ||
'''Haridra''' ('' | '''Haridra''' (''Curcuma longa'' L.), widely known as turmeric, is a perennial rhizomatous herb of the family Zingiberaceae<ref name="Fuloria2022">{{cite journal |last1=Fuloria |first1=Shivkanya |last2=Mehta |first2=Jyoti |last3=Chandel |first3=Aditi |last4=Sekar |first4=Mahendran |last5=Rani |first5=Nur Najihah Izzati Mat |year=2022 |title=A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin |journal=Frontiers in Pharmacology |volume=13 |pages=820806 |doi=10.3389/fphar.2022.820806 |pmc=8990857}}</ref>. Celebrated in [[Ayurveda|Ayurvedic medicine]] for millennia as a potent ''Vishaghna'' (antitoxic), ''Kushthaghna'' (alleviator of skin diseases), and ''Pramehahara'' (antidiabetic) agent, modern pharmacological research has extensively validated its molecular mechanisms<ref name="Razavi2021">{{cite journal |last1=Razavi |first1=Bibi Marjan |last2=Ghasemzadeh Rahbardar |first2=Mahboobeh |last3=Hosseinzadeh |first3=Hossein |year=2021 |title=A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents |journal=Phytotherapy Research |volume=35 |issue=12 |pages=6489–6513 |doi=10.1002/ptr.7224 |pmid=34312922}}</ref>. Its therapeutic actions are primarily driven by polyphenolic curcuminoids and volatile sesquiterpenes<ref name="Hewlings2017">{{cite journal |last1=Hewlings |first1=Susan J. |last2=Kalman |first2=Douglas S. |year=2017 |title=Curcumin: A Review of Its Effects on Human Health |journal=Foods |volume=6 |issue=10 |pages=92 |doi=10.3390/foods6100092 |pmid=29065496 |pmc=5664031}}</ref>. | ||
==Therapeutic Uses== | ==Therapeutic Uses== | ||
| Line 95: | Line 85: | ||
| 4 || Qualities ([[guna]])|| Rough (ruksha), Light (laghu) | | 4 || Qualities ([[guna]])|| Rough (ruksha), Light (laghu) | ||
|- | |- | ||
| 5 || Actions ([[karma]]) || Pacify [[kapha]], [[vata]] and [[pitta]]. It also expels the [[pitta]] (pitta rechak) | | 5 || Actions ([[karma]]) || Pacify [[kapha]], [[vata]] and [[pitta]]. It also expels the [[pitta]] (pitta rechak) | ||
|- | |- | ||
|6 | |||
|Therapeutics | |||
|Varnya (Complexion enhancing), Krimighna (Antimicrobial/Antiparasitic), Pramehahara (Anti-diabetic), Lekhana (Scraping/Anti-lipidemic), Vrana Ropana(Wound healing) | |||
|} | |} | ||
| Line 117: | Line 110: | ||
|- | |- | ||
| 6 ||Cha.Sa.[[Kalpa Sthana]] 7/16 || Preparations of Trivrut | | 6 ||Cha.Sa.[[Kalpa Sthana]] 7/16 || Preparations of Trivrut | ||
|} | |} | ||
==Dose== | ==Dose== | ||
1-3 gm of the drug in powder form.<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:30</ref> | |||
==Important Formulations== | ==Important Formulations== | ||
| Line 149: | Line 140: | ||
! Compound Category !! Major Constituents !! Biological Significance | ! Compound Category !! Major Constituents !! Biological Significance | ||
|- | |- | ||
| ''' | | '''Curcuminoids''' (~3–6%) || Curcumin (Curcumin I), Demethoxycurcumin (Curcumin II), Bisdemethoxycurcumin (Curcumin III) || Primary anti-inflammatory, antioxidant, neuroprotective, and antineoplastic agents. | ||
|- | |- | ||
| '''Volatile Essential Oils''' (~3–7%) | | | '''Volatile Essential Oils''' (~3–7%) || α-turmerone, β-turmerone, ar-turmerone, α-atlantone, xanthorrhizol || Antimicrobial, neurogenic, anti-fungal, and bioavailability-enhancing properties. | ||
|} | |} | ||
| Line 157: | Line 148: | ||
=== Anti-inflammatory & Immunomodulatory Efficacy === | === Anti-inflammatory & Immunomodulatory Efficacy === | ||
Curcumin acts as a multi-target anti-inflammatory agent. Unlike synthetic | Curcumin acts as a multi-target anti-inflammatory agent. Unlike synthetic NSAIDs that target specific enzymes, curcumin downregulates key inflammatory cascades<ref name="Hewlings2017"/>: | ||
* '''Inhibition of | * '''Inhibition of NF-κB Pathway:''' Suppresses nuclear factor kappa B (NF-κB) activation, inhibiting downstream pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8<ref name="Razavi2021"/>. | ||
* '''Enzymatic Downregulation:''' Directly inhibits cyclooxygenase-2 (''' | * '''Enzymatic Downregulation:''' Directly inhibits cyclooxygenase-2 ('''COX-2'''), 5-lipoxygenase ('''5-LOX'''), and inducible nitric oxide synthase ('''iNOS''')<ref name="Hewlings2017"/>. | ||
Systematic reviews and meta-analyses of randomized controlled trials (RCTs) confirm that turmeric extracts significantly reduce joint pain and stiffness in knee | Systematic reviews and meta-analyses of randomized controlled trials (RCTs) confirm that turmeric extracts significantly reduce joint pain and stiffness in knee osteoarthritis patients with efficacy comparable to ibuprofen, but with fewer gastrointestinal adverse events<ref name="Daily2016">{{cite journal |last1=Daily |first1=James W. |last2=Yang |first2=Mini |last3=Park |first3=Sunmin |year=2016 |title=Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials |journal=Journal of Medicinal Food |volume=19 |issue=8 |pages=717–729 |doi=10.1089/jmf.2016.3705 |pmid=27533649 |pmc=5003001}}</ref><ref name="Zeng2022">{{cite journal |last1=Zeng |first1=Liuting |last2=Yang |first2=Tiejun |last3=Yang |first3=Kailin |last4=Yu |first4=Ganpeng |last5=Li |first5=Jun |year=2022 |title=Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial |journal=Frontiers in Immunology |volume=13 |pages=891822 |doi=10.3389/fimmu.2022.891822 |pmc=9353077}}</ref>. | ||
=== Antioxidant & Cytoprotective Activity === | === Antioxidant & Cytoprotective Activity === | ||
Curcumin functions both as a direct free-radical scavenger and as an inducer of endogenous antioxidant defenses<ref name="Hewlings2017"/>: | Curcumin functions both as a direct free-radical scavenger and as an inducer of endogenous antioxidant defenses<ref name="Hewlings2017"/>: | ||
* Scavenges | * Scavenges reactive oxygen species (ROS) and reactive nitrogen species (RNS). | ||
* Activates the ''' | * Activates the '''Nrf2-ARE pathway''', upregulating phase II detoxifying enzymes, including superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and heme oxygenase-1 (HO-1)<ref name="Hewlings2017"/>. | ||
=== Metabolic & Antidiabetic Actions === | === Metabolic & Antidiabetic Actions === | ||
Aligning with its classical classification as a ''Pramehahara'' herb, ''Curcuma longa'' exhibits pronounced metabolic regulation<ref name="Fuloria2022"/>: | Aligning with its classical classification as a ''Pramehahara'' herb, ''Curcuma longa'' exhibits pronounced metabolic regulation<ref name="Fuloria2022"/>: | ||
* ''' | * '''AMPK Activation:''' Activates AMPK, suppressing hepatic gluconeogenesis and enhancing glucose uptake in skeletal muscle. | ||
* '''Insulin Sensitivity:''' Improves insulin receptor phosphorylation and downregulates inflammatory markers in adipose tissue that drive | * '''Insulin Sensitivity:''' Improves insulin receptor phosphorylation and downregulates inflammatory markers in adipose tissue that drive insulin resistance. | ||
* '''Lipid Modulation:''' Lowers serum | * '''Lipid Modulation:''' Lowers serum low-density lipoprotein (LDL) cholesterol and triglycerides while raising high-density lipoprotein (HDL) levels through PPAR-γ modulation<ref name="Hewlings2017"/>. | ||
=== Neuroprotective & Cognitive Efficacy === | === Neuroprotective & Cognitive Efficacy === | ||
* ''' | * '''Amyloid-β Aggregation Inhibition:''' Curcumin crosses the blood–brain barrier, directly binding to and destabilizing amyloid-beta plaques in Alzheimer's disease models<ref name="Noorafshan2013">{{cite journal |last1=Noorafshan |first1=Ali |last2=Ashkani-Esfahani |first2=Soheil |year=2013 |title=A Review of Therapeutic Effects of Curcumin |journal=Current Pharmaceutical Design |volume=19 |issue=11 |pages=2032–2046 |doi=10.2174/1381612811319110006 |pmid=23116311}}</ref>. | ||
* '''Neurogenesis Promotion:''' ''ar-Turmerone'' has been shown to induce | * '''Neurogenesis Promotion:''' ''ar-Turmerone'' has been shown to induce neural stem cell proliferation and differentiation. | ||
* '''BDNF Upregulation:''' Elevates | * '''BDNF Upregulation:''' Elevates Brain-Derived Neurotrophic Factor (BDNF) levels, counteracting neurodegenerative processes and stress-induced cognitive decline<ref name="Noorafshan2013"/>. | ||
=== Wound Healing & Dermatological Applications === | === Wound Healing & Dermatological Applications === | ||
Traditional use as ''Vrana Ropana'' (wound healer) is validated by its ability to accelerate tissue repair<ref name="Fuloria2022"/>: | Traditional use as ''Vrana Ropana'' (wound healer) is validated by its ability to accelerate tissue repair<ref name="Fuloria2022"/>: | ||
* Enhances | * Enhances epithelialization, increases collagen deposition, and speeds up tissue remodeling. | ||
* Exhibits broad-spectrum antibacterial activity against pathogens such as '' | * Exhibits broad-spectrum antibacterial activity against pathogens such as ''Staphylococcus aureus'' and ''Pseudomonas aeruginosa''. | ||
== Bioavailability & Pharmacokinetic Strategies == | == Bioavailability & Pharmacokinetic Strategies == | ||
Despite high bioactivity ''in vitro'', native curcumin displays poor systemic | Despite high bioactivity ''in vitro'', native curcumin displays poor systemic bioavailability due to low aqueous solubility, poor intestinal absorption, and rapid hepatic metabolism (glucuronidation and sulfation)<ref name="Anand2007">{{cite journal |last1=Anand |first1=Preetha |last2=Kunnumakkara |first2=Ajaikumar B. |last3=Newman |first3=Robert A. |last4=Aggarwal |first4=Bharat B. |year=2007 |title=Bioavailability of curcumin: problems and promises |journal=Molecular Pharmaceutics |volume=4 |issue=6 |pages=807–818 |doi=10.1021/mp070113r |pmid=17999464}}</ref>. | ||
Modern delivery formulations overcome these barriers: | Modern delivery formulations overcome these barriers: | ||
* ''' | * '''Piperine Synergy:''' Co-administration with piperine (from ''Piper nigrum'') increases bioavailability by '''2000%''' by inhibiting hepatic and intestinal glucuronidation<ref name="Anand2007"/>. | ||
* '''Liposomal & Nanoparticulate Curcumin:''' Enhances cellular uptake and extends plasma half-life<ref name="Anand2007"/>. | * '''Liposomal & Nanoparticulate Curcumin:''' Enhances cellular uptake and extends plasma half-life<ref name="Anand2007"/>. | ||
* '''Phytosome Formulations:''' Complexing curcumin with phospholipids improves oral absorption significantly compared to unformulated extracts. | * '''Phytosome Formulations:''' Complexing curcumin with phospholipids improves oral absorption significantly compared to unformulated extracts. | ||
== Safety, Toxicology & Contraindications == | == Safety, Toxicology & Contraindications == | ||
* ''' | * '''GRAS Status:''' Curcumin is recognized as GRAS by the US FDA. Clinical trials confirm safety at oral doses up to '''8,000 to 12,000 mg/day'''<ref name="Hewlings2017"/><ref name="Anand2007"/>. | ||
* '''Adverse Effects:''' Mild gastrointestinal upset (nausea, diarrhea, dyspepsia) may occur at very high doses. | * '''Adverse Effects:''' Mild gastrointestinal upset (nausea, diarrhea, dyspepsia) may occur at very high doses. | ||
* '''Contraindications:''' | * '''Contraindications:''' | ||
** ''' | ** '''Biliary Obstruction:''' Contraindicated in acute bile duct obstruction or gallstones due to its cholagogic effect (stimulation of gallbladder contraction). | ||
** '''Bleeding Disorders:''' May exert mild antiplatelet effects; exercise caution when combining with anticoagulant medications (e.g., | ** '''Bleeding Disorders:''' May exert mild antiplatelet effects; exercise caution when combining with anticoagulant medications (e.g., Warfarin, Aspirin). | ||
== References == | == References == | ||
| Line 211: | Line 202: | ||
[https://cb.imsc.res.in/imppat/phytochemical-detailedpage/IMPHY007574 IMPPAT database] | [https://cb.imsc.res.in/imppat/phytochemical-detailedpage/IMPHY007574 IMPPAT database] | ||
[[Category:Database of herbs and minerals|Herbs]] | [[index.php?title=Category:Database of herbs and minerals|Herbs]] | ||